Athena Countouriotis Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Athena Countouriotis is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 13,550 shares of BMRN, which is worth approximately $778,854. The most recent transaction as insider was on May 20, 2025, when has been sold 6,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.6K

96.38% 3M change

96.38% 12M change

Total Value Held $778,854

Athena Countouriotis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	BUY Grant, award, or other acquisition	-	6,650 Added 32.92%	13,550 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	4,720 Added 40.62%	6,900 Common Stock
Dec 27 2023	BUY Grant, award, or other acquisition	-	2,180 Added 50.0%	2,180 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

President & CEO

PASG

Passage BIO, Inc. Healthcare

IOVA

IOVANCE BIOTHERAPEUTICS, INC. Healthcare

Director